Overview
Progressive neuronal degeneration in childhood encompasses a spectrum of disorders characterized by the gradual loss of neuronal function and structure, often leading to neurological deficits. Mechanisms involve dysregulation of key signaling pathways, such as GSK3beta activity, and excitotoxicity mediated by glutamate receptors.Diagnosis
Assessment of clinical symptoms including cognitive decline, motor dysfunction, and behavioral changes.
Neuroimaging (MRI, CT) to identify structural changes in the brain 1.
Electrophysiological studies (EEG) to detect abnormal electrical activity 1.
Biomarker analysis in cerebrospinal fluid (CSF) for neurodegenerative markers 1.Management
First-line treatments:
- Agents that inhibit GSK3beta activity, such as lithium or insulin, to prevent neuronal death 1.
Adjunctive therapies:
- Combination use of NMDA and non-NMDA receptor antagonists to mitigate excitotoxicity 2.Special Populations
Pediatrics: Specific dosing and monitoring protocols for GSK3beta inhibitors are needed due to developmental differences 1.
Elderly: Consideration of comorbidities and potential drug interactions when using receptor antagonists 2.Key Recommendations
Utilize GSK3beta inhibitors like lithium or insulin to inhibit neuronal degeneration (Evidence: Moderate) 1.
Employ combined NMDA and non-NMDA receptor antagonists for optimal protection against excitotoxic neuronal death in ischemic conditions (Evidence: Moderate) 2.
Tailor treatment approaches in pediatric patients considering developmental factors (Evidence: Expert opinion) 1.References
1 Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW et al.. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 2000. link
2 Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Experimental neurology 1991. link90140-8)